Utpal Koppikar - 08 Feb 2023 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
08 Feb 2023
Net transactions value
+$31,735
Form type
4
Filing time
10 Feb 2023, 15:27:22 UTC
Previous filing
09 Feb 2023
Next filing
06 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Purchase $31,735 +5,667 $5.60 5,667 08 Feb 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.